About Evox Therapeutics Ltd.
Evox Therapeutics is an innovative biotechnology company pioneering next-generation genetic medicines for severe neurodegenerative diseases. Based at Oxford Science Park, Evox combines proprietary exosome delivery technologies with advanced genome-editing approaches to develop targeted therapies for diseases including Huntington’s disease and ALS. With a multidisciplinary team and strong academic and industry partnerships, Evox offers an exciting opportunity to work at the forefront of genetic medicine and help advance transformative therapies from discovery toward the clinic.